Ok Biotech (Taiwan) Insiders
| 4155 Stock | 22.30 0.10 0.45% |
Ok Biotech employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 12 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Ok Biotech's management performance can provide insight into the venture performance.
| Jia Lai Chairman Chairman Director |
4155 |
Ok Biotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0799 %, meaning that it generated $0.0799 on every $100 dollars invested by stockholders. Ok Biotech's management efficiency ratios could be used to measure how well Ok Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Ok Biotech Workforce Comparison
Ok Biotech Co is rated below average in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 246. Ok Biotech holds roughly 5.0 in number of employees claiming about 2.03% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Ok Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Ok Biotech Price Series Summation is a cross summation of Ok Biotech price series and its benchmark/peer.
Ok Biotech Notable Stakeholders
An Ok Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ok Biotech often face trade-offs trying to please all of them. Ok Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ok Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jia Lai | Chairman Director | Profile | |
| De Wang | Director Associate | Profile | |
| De Zhang | Deputy Officer | Profile | |
| Qi Hou | Financial Mang | Profile | |
| Zi Huang | Head Audit | Profile |
About Ok Biotech Management Performance
The success or failure of an entity such as Ok Biotech often depends on how effective the management is. Ok Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 4155 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 4155 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Ok Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ok Biotech Co. Check Ok Biotech's Beneish M Score to see the likelihood of Ok Biotech's management manipulating its earnings.
Ok Biotech Workforce Analysis
Traditionally, organizations such as Ok Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ok Biotech within its industry.Ok Biotech Manpower Efficiency
Return on Ok Biotech Manpower
| Revenue Per Employee | 252.7M | |
| Revenue Per Executive | 252.7M | |
| Net Income Per Employee | 8.7M | |
| Net Income Per Executive | 8.7M |
Additional Tools for 4155 Stock Analysis
When running Ok Biotech's price analysis, check to measure Ok Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ok Biotech is operating at the current time. Most of Ok Biotech's value examination focuses on studying past and present price action to predict the probability of Ok Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ok Biotech's price. Additionally, you may evaluate how the addition of Ok Biotech to your portfolios can decrease your overall portfolio volatility.